210 related articles for article (PubMed ID: 30375919)
21. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation.
Ivanov D; Kwak YT; Nee E; Guo J; García-Martínez LF; Gaynor RB
J Mol Biol; 1999 Apr; 288(1):41-56. PubMed ID: 10329125
[TBL] [Abstract][Full Text] [Related]
22. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.
Romano G; Kasten M; De Falco G; Micheli P; Khalili K; Giordano A
J Cell Biochem; 1999 Dec; 75(3):357-68. PubMed ID: 10536359
[TBL] [Abstract][Full Text] [Related]
23. CDK9: a signaling hub for transcriptional control.
Bacon CW; D'Orso I
Transcription; 2019 Apr; 10(2):57-75. PubMed ID: 30227759
[TBL] [Abstract][Full Text] [Related]
24. Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7.
Tamrakar S; Kapasi AJ; Spector DH
J Virol; 2005 Dec; 79(24):15477-93. PubMed ID: 16306619
[TBL] [Abstract][Full Text] [Related]
25. Cdk7: a kinase at the core of transcription and in the crosshairs of cancer drug discovery.
Fisher RP
Transcription; 2019 Apr; 10(2):47-56. PubMed ID: 30488763
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy.
Holcakova J; Muller P; Tomasec P; Hrstka R; Nekulova M; Krystof V; Strnad M; Wilkinson GW; Vojtesek B
PLoS One; 2014; 9(2):e89228. PubMed ID: 24586613
[TBL] [Abstract][Full Text] [Related]
27. Targeting of CDK8 to a promoter-proximal RNA element demonstrates catalysis-dependent activation of gene expression.
Gold MO; Rice AP
Nucleic Acids Res; 1998 Aug; 26(16):3784-8. PubMed ID: 9685496
[TBL] [Abstract][Full Text] [Related]
28. Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.
Zhou M; Deng L; Lacoste V; Park HU; Pumfery A; Kashanchi F; Brady JN; Kumar A
J Virol; 2004 Dec; 78(24):13522-33. PubMed ID: 15564463
[TBL] [Abstract][Full Text] [Related]
29. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
[TBL] [Abstract][Full Text] [Related]
30. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
Fujinaga K; Irwin D; Geyer M; Peterlin BM
J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
[TBL] [Abstract][Full Text] [Related]
31. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain.
Parada CA; Roeder RG
Nature; 1996 Nov; 384(6607):375-8. PubMed ID: 8934526
[TBL] [Abstract][Full Text] [Related]
32. Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II.
Lu H; Yu D; Hansen AS; Ganguly S; Liu R; Heckert A; Darzacq X; Zhou Q
Nature; 2018 Jun; 558(7709):318-323. PubMed ID: 29849146
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo.
Majello B; Napolitano G; Giordano A; Lania L
Oncogene; 1999 Aug; 18(32):4598-605. PubMed ID: 10467404
[TBL] [Abstract][Full Text] [Related]
34. Tackling Tat.
Karn J
J Mol Biol; 1999 Oct; 293(2):235-54. PubMed ID: 10550206
[TBL] [Abstract][Full Text] [Related]
35. The CDK Network: Linking Cycles of Cell Division and Gene Expression.
Fisher RP
Genes Cancer; 2012 Nov; 3(11-12):731-8. PubMed ID: 23634260
[TBL] [Abstract][Full Text] [Related]
36. RNA glycosidase and other agents target Tat to inhibit HIV-1 transcription.
Harrich D; Jin H
Biochem J; 2018 Mar; 475(6):1059-1062. PubMed ID: 29559581
[TBL] [Abstract][Full Text] [Related]
37. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA.
Wei P; Garber ME; Fang SM; Fischer WH; Jones KA
Cell; 1998 Feb; 92(4):451-62. PubMed ID: 9491887
[TBL] [Abstract][Full Text] [Related]
38. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
[TBL] [Abstract][Full Text] [Related]
39. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription.
Barboric M; Yik JH; Czudnochowski N; Yang Z; Chen R; Contreras X; Geyer M; Matija Peterlin B; Zhou Q
Nucleic Acids Res; 2007; 35(6):2003-12. PubMed ID: 17341462
[TBL] [Abstract][Full Text] [Related]
40. Three cyclin-dependent kinases preferentially phosphorylate different parts of the C-terminal domain of the large subunit of RNA polymerase II.
Pinhero R; Liaw P; Bertens K; Yankulov K
Eur J Biochem; 2004 Mar; 271(5):1004-14. PubMed ID: 15009212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
